Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001847367-25-000019
Filing Date
2025-04-23
Accepted
2025-04-23 16:10:23
Documents
17
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A alms-20241231x10ka.htm   iXBRL 10-K/A 608471
2 EX-31.3 alms-20241231xex31d3.htm EX-31.3 8331
3 EX-31.4 alms-20241231xex31d4.htm EX-31.4 10782
  Complete submission text file 0001847367-25-000019.txt   1032227

Data Files

Seq Description Document Type Size
4 EX-101.SCH alms-20241231.xsd EX-101.SCH 4922
5 EX-101.DEF alms-20241231_def.xml EX-101.DEF 45606
6 EX-101.LAB alms-20241231_lab.xml EX-101.LAB 30292
7 EX-101.PRE alms-20241231_pre.xml EX-101.PRE 20845
19 EXTRACTED XBRL INSTANCE DOCUMENT alms-20241231x10ka_htm.xml XML 10077
Mailing Address 280 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 280 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 650-231-6625
ALUMIS INC. (Filer) CIK: 0001847367 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-42143 | Film No.: 25861543
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)